Clinical Trial Update: Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study of armodafinil for excessive sleepiness in narcolepsy completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: Cephalon | Conditions: Narcolepsy | Phase 3 | Status: COMPLETED | Results posted: 2010-01-21